Cedar Mountain Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Cedar Mountain Advisors's FBT Position: Q2 2026 in Review
Cedar Mountain Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 90 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #313.
Cedar Mountain Advisors first reported a position in FBT in Q4 2019 and has held it in 27 quarters since. The position peaked at $42K in Q2 2021. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Cedar Mountain Advisors held 90 shares of First Trust NYSE Arca Biotechnology Index Fund worth $22.3K as of Q2 2026.
- Cedar Mountain Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #313 holding.
- Cedar Mountain Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 27 quarters since.
- Cedar Mountain Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $42K in Q2 2021.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.